Markets rose this week as the most recent housing numbers impressed analysts. Building permits, housing starts, and existing home sales all beat expectations, while the NAHB housing index remains firmly in expansionary territory. In other good news, PMI numbers on both the service and manufacturing […]
In this month’s portfolio recap, we touch on the current allocation of our models and what factors have been driving performance. To watch this update, click the play button above.
Markets rose to all time highs this week even as December hiring numbers disappointed. Consensus expectations were for positive hiring in the 50K range, but came in negative at -140K. The official unemployment rate fell further, ending 2020 at 6.7%. Encouragingly, December PMI data impressed […]
Stocks rose this week as the federal government was reportedly near to passing a second stimulus package. Proponents for stimulus have argued that a new stimulus package was absolutely critical and that the recovery would stall or even reverse without it. Congress agreed to pass […]
Stocks fell this week even as consumer sentiment beat expectations and the world started implementing vaccination efforts. In the U.S., Pfizer’s COVID-19 vaccine is officially
Stocks rose this week even as nonfarm payrolls came in well under expectations in November. Markets continue to be encouraged by the progress in COVID-19 vaccine situation, and many countries will begin administering vaccines this month. Globally, COVID-19 infections continue to increase, underscoring the positive […]
Thanksgiving week has come and gone, officially kicking off the Christmas season. Stocks rose this week as markets continue to be encouraged by the progress in COVID-19 vaccine trials. Globally, COVID-19 infections continue to increase. New daily infections in the U.S. remain stubbornly above 100K. […]
Stocks were mixed this week as pharmaceutical company Moderna became the second company in as many weeks to have a high success rate with their COVID-19 vaccine trials. Globally, COVID-19 infections continue to increase. New daily infections in the U.S. remain above 100K. Economic data […]
Stocks climbed significantly this week as Pfizer announced a high success rate with their COVID-19 vaccine trials. Good news on the battle front against the pandemic was warmly welcomed as COVID-19 infections continue to increase, with new daily infections in the U.S. remaining above 100K. […]
Stocks climbed significantly this week as the U.S. presidential election has been called for Democratic candidate Joe Biden. COVID-19 infections continue to increase, with new daily infections rising above 100K for the first time. Economic data impressed this week with manufacturing data, official unemployment rates […]
QUICK LINKS
Home | About Us | Our Process | Getting Started | Events | Guides | Blog | Books | SmartVestor | Contact Us
OUR SERVICES
Income Planning | Investment Planning | Tax Planning | Long-Term Care | HealthCare Planning | Legacy and Estate Planning | Annuities
© Juniper Wealth Management – Powered by: Simplicity Lone Beacon
Terms and Conditions | Privacy Policy | ADV 2A | CRS Summary
Investment advisory and financial planning services are offered through Simplicity Wealth, LLC, an SEC-registered investment adviser. SEC registration does not constitute an endorsement of the firm, nor does it indicate that the adviser has attained a particular level of skill or ability. Insurance, Consulting and Education services offered through Juniper Wealth Management. Juniper Wealth Management is a separate and unaffiliated entity from Simplicity Wealth.
This information is designed to provide general information on the subjects covered, it is not, however, intended to provide specific legal or tax advice and cannot be used to avoid tax penalties or to promote, market, or recommend any tax plan or arrangement. Please note that Juniper Wealth Management and its affiliates do not give legal or tax advice. You are encouraged to consult your tax advisor or attorney.
Annuity guarantees rely on the financial strength and claims-paying ability of the issuing insurer. Any references to protection benefits or lifetime income generally refer to fixed insurance products. They do not refer, in any way to securities or investment advisory products or services. Fixed Insurance and Annuity product guarantees are subject to the claims‐paying ability of the issuing company and are not offered by Retirement Wealth Advisors, Inc.